HOME >> MEDICINE >> NEWS
OHSU Cancer Institute researcher identifies protein marker for prostate cancer survival

PORTLAND, Ore. Oregon Health & Science University Cancer Institute researchers have identified a protein that is a strong indicator of survival for men with advanced prostate cancer. The C-reactive protein, also known as CRP, is a special type of protein produced by the liver that is elevated in the presence of inflammation.

"This could mean that a simple blood test that is already available could help patients and doctors make better decisions as they become more informed about what to expect from the prostate cancer they are facing," said Tomasz Beer, M.D., director of the Prostate Cancer Research program at the OHSU Cancer Institute, associate professor of medicine, (hematology/medical oncology) OHSU School of Medicine.

Beer's research will be presented Friday, June 1 (CST) at the 43rd annual meeting of the American Society of Clinical Oncologists in Chicago. Julie Graff, M.D., OHSU Cancer Institute member, division of hematology and medical oncology, will present the research.

It has been known that cancer causes an inflammatory response. This research also suggests that inflammation may play an important role in driving prostate cancer progression and resistance to therapy.

"While sometimes inflammation may slow the cancer, an increasing body of evidence suggests that cancer can take advantage of the inflammatory response and the inflammatory cytokines released by the immune reaction may in fact fuel cancer progression. To the extent that our hypothesis proves true, C-reactive protein may be reflecting the overall intensity of the inflammation," Beer said.

The finding that higher CRP is associated with shorter survival and a lower probability of response to chemotherapy is a result of a secondary analysis of inflammatory markers in subjects enrolled in the ASCENT study, a large Phase 2 clinical trial that evaluated treatment with docetaxel and DN-101, a high dose formulation of calcitriol or docetaxel with
'"/>

Contact: Christine Decker
deckerch@ohsu.edu
503-494-8231
Oregon Health & Science University
1-Jun-2007


Page: 1 2

Related medicine news :

1. American Cancer Society to hold third annual Virtual Relay For Life in Second Life
2. Cancer research summaries
3. Cancer on the agenda of the Portuguese EU Council Presidency
4. Tony Hunter receives Robert. J. and Claire Pasarow Award for Cancer Research
5. OHSU Cancer Institute shows findings of immunotherapy vaccine in prostate cancer patients
6. OHSU Cancer Institute, VA researchers find way to identify which men need a second biopsy
7. Ireland Cancer Center researcher lays out benefits of aspirin to prevent colon cancer
8. Mayo Clinic Cancer Center researcher finds mold by-product kills multiple myeloma
9. Margaret Foti receives AACR Award for Leadership and Extraordinary Achievements in Cancer Research
10. Cancer-fighting foods, supplements explored in day-long symposium, March 25
11. Cancer vaccine innovator honored with prestigious Florey Medal

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/17/2019)... ... , ... Knotty Roller, the affordable all-in-one muscle recovery system with six tools ... than $20,000 in only eleven hours after launching on Kickstarter . , “We’re ... enjoy the ease of use and versatility of our product,” said Knotty Roller CEO ...
(Date:10/17/2019)... ... 17, 2019 , ... A clinical article reviewing the long-term performance of the ... at Plastic Surgery - The Meeting 2019 in San Diego last month. The article, ... by Larry S. Nichter, M.D., Robert A. Hardesty, M.D., and Gregg M. Anigian, M.D., ...
(Date:10/15/2019)... ... , ... Khalieghya Dandie-Evans, a liver transplant recipient from Richmond, Calif. was chosen ... float in the 131st Rose Parade® on New Year’s Day. She will represent the ... Nevada, the organization’s service area. , Khalieghya, 17, grew up believing it was “normal” ...
(Date:10/15/2019)... CHURCH, Va. (PRWEB) , ... October 15, 2019 ... ... Products:, Complying with FDA’s Most Recent IFU Guidance , **An FDAnews Webinar**, Tuesday, ... the recent Instructions for Use (IFU) guidance have on new drug applications and ...
(Date:10/15/2019)... ... ... Genomenon® announced today at the American Society of Human Genetics ... Mastermind® Genomic Search Engine into the SOPHiA Platform and the Alamut ... clinical researchers performing genomic analysis worldwide. , The SOPHiA Platform is the ...
Breaking Medicine News(10 mins):
(Date:10/15/2019)... FORESIDE, Maine (PRWEB) , ... ... ... Standards1 releases VALIDATE® LP2 linearity and calibration verification kit, for Roche cobas® ... A (Apo-A1) and Apolipoprotein B (Apo-B). Each VALIDATE® LP2 kit, liquid, ...
(Date:10/11/2019)... ... October 11, 2019 , ... Five New York fitness studios have teamed up to create ... opportunity to tour and sample a variety of the top group exercise classes offered on ... produced by Club Pilates on W. 57th St., the Hell’s Kitchen Sweat Crawl will feature ...
(Date:10/10/2019)... ... October 10, 2019 , ... Ovation Fertility is once ... of reproductive medicine, with six abstracts accepted for poster presentations at the ASRM ... October 12-16, 2019, in Philadelphia. , “Ovation will have a prominent presence in ...
Breaking Medicine Technology:
Cached News: